ReviewImmunotherapy2010

Immunotherapeutic options for Epstein-Barr virus-associated lymphoproliferative disease following transplantation.

Donald R Shaffer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.